| Outgoing Relation(s) |
| fibroblast growth factor receptor antagonist (CHEBI:63457) is a antagonist (CHEBI:48706) |
| Incoming Relation(s) |
| 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoic acid (CHEBI:73307) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| AZD4547 (CHEBI:63453) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| BGJ-398 (CHEBI:63451) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| brivanib (CHEBI:167686) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| brivanib alaninate (CHEBI:167656) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| E-3810 (CHEBI:65138) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| E-3810 free base (CHEBI:65209) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| lenvatinib (CHEBI:85994) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| lenvatinib mesylate (CHEBI:85995) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| nintedanib (CHEBI:85164) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| nintedanib esylate (CHEBI:85170) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| PD173074 (CHEBI:63448) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| sodium 2-amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate (CHEBI:73280) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
| SU5402 (CHEBI:63449) has role fibroblast growth factor receptor antagonist (CHEBI:63457) |
